PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>42</strong>/<strong>2000</strong><br />
15152 <strong>PCT</strong> <strong>Gazette</strong> - Section I - <strong>Gazette</strong> du <strong>PCT</strong> 19 Oct/oct <strong>2000</strong><br />
(30) PA 1999 00486 13 Apr/avr 1999<br />
(13.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
DK<br />
(54) SOLUBILIZED PHARMACEUTICAL<br />
COMPOSITION FOR PARENTERAL<br />
ADMINISTRATION<br />
COMPOSITION PHARMACEUTIQUE<br />
SOLUBILISEE A ADMINISTRATION<br />
PARENTERALE<br />
(71) LEO PHARMACEUTICAL PRODUCTS<br />
LTD. A/S (LØVENS KEMISKE FABRIK<br />
PRODUKTIONSAKTIESELSKAB)<br />
[DK/DK]; Industriparken 55, DK–2750<br />
Ballerup (DK).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) DIDRIKSEN, Erik, Johannes<br />
[DK/DK]; Fuglehavevej 14, DK–2750<br />
Ballerup (DK). GERLACH, Anette, Leth<br />
[DK/DK]; Hjortevænget 15, DK–3450 Allerød<br />
(DK).<br />
(74) KINZEBACH, Werner et al. / etc.;<br />
Reitstötter, Kinzebach & Partner, Sternwartstrasse<br />
4, D–81679 München (DE).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM EE ES<br />
FI GB GD GE GH GM HR HU ID IL IN<br />
IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MA MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ<br />
TM TR TT TZ UA UG US UZ VN YU ZA<br />
ZW; AP (GH GM KE LS MW SD SL SZ<br />
TZ UG ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE);<br />
OA (BF BJ CF CG CI CM GA GN GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 9/107, 9/48, 47/24, 9/127<br />
(11) WO 00/61113 (13) A1<br />
(21) <strong>PCT</strong>/GB00/01361<br />
(22) 11 Apr/avr <strong>2000</strong> (11.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 9908309.9 12 Apr/avr 1999<br />
(12.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
GB<br />
(54) LIPID AGGREGATE FORMING<br />
COMPOSITIONS AND THEIR USES<br />
COMPOSITIONS FORMANT DES<br />
AGREGATS LIPIDIQUES, ET LEURS<br />
UTILISATIONS<br />
(71) PHARES PHARMACEUTICALS RE-<br />
SEARCH N.V. [NL/NL]; 14 John B<br />
Gorsiraweg, P.O. Box 3889, Curacao (AN).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) LEIGH, Steven [GB/GB]; Lucas &<br />
Co., 135 Westhall Road, Warlingham, Surrey<br />
CR6 9HJ (GB). LEIGH, Mathew, Louis,<br />
Steven [GB/GB]; Lucas & Co., 135 Westhall<br />
Road, Warlingham, Surrey CR6 9HJ (GB).<br />
(74) COLE, Paul, Gilbert; Lucas & Co., 135<br />
Westhall Road, Warlingham, Surrey CR6<br />
9HJ (GB).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 A61K 9/127, A61P 35/00<br />
(11) WO 00/61114 (13) A1<br />
(21) <strong>PCT</strong>/JP00/02272<br />
(22) 7 Apr/avr <strong>2000</strong> (07.04.<strong>2000</strong>)<br />
(25) ja (26) ja<br />
(30) 11/101020 8 Apr/avr 1999<br />
(08.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) FINE PARTICLES TARGETING CELLS<br />
AND PROCESS FOR PRODUCING<br />
THE SAME<br />
PARTICULES FINES CIBLANT DES<br />
CELLULES, ET PROCEDE DE PRO-<br />
DUCTION CORRESPONDANT<br />
(71) MITSUBISHI CHEMICAL CORPORA-<br />
TION [JP/JP]; 5–2, Marunouchi 2–chome,<br />
Chiyoda–ku, Tokyo 100–0005 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) TAGAWA, Toshiaki [JP/JP]; Mitsubishi–Tokyo<br />
Pharmaceuticals, Inc., Yokohama<br />
Research Center, 1000, Kamoshida–cho,<br />
Aoba–ku, Yokohama–shi, Kanagawa<br />
227–0033 (JP). NIKI, Hisae [JP/JP];<br />
Mitsubishi–Tokyo Pharmaceuticals, Inc.,<br />
Yokohama Research Center, 1000, Kamoshida–cho,<br />
Aoba–ku, Yokohama–shi, Kanagawa<br />
227–0033 (JP). SAISHO, Tomoko<br />
[JP/JP]; Mitsubishi–Tokyo Pharmaceuticals,<br />
Inc., Yokohama Research Center, 1000,<br />
Kamoshida–cho, Aoba–ku, Yokohama–shi,<br />
Kanagawa 227–0033 (JP). MARUYAMA,<br />
Kazuo [JP/JP]; 15–12, Aihara 5–chome,<br />
Sagamihara–shi, Kanagawa 229–1101 (JP).<br />
(74) MATSUYAMA, Naoyuki et al. / etc.; Mitsubishi–Tokyo<br />
Pharmaceuticals, Inc., 2–6,<br />
Nihonbashi–honcho 2–chome, Chuo–ku, Tokyo<br />
103–8405 (JP).<br />
(81) AU CA CN JP KR US; EP (AT BE CH CY<br />
DE DK ES FI FR GB GR IE IT LU MC NL<br />
PT SE).<br />
(51) 7 A61K 9/20, 31/43, A61P 31/04<br />
(11) WO 00/61115 (13) A2<br />
(21) <strong>PCT</strong>/IB00/00979<br />
(22) 11 Apr/avr <strong>2000</strong> (11.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 60/129,074 13 Apr/avr 1999<br />
(13.04.1999)<br />
(30) 60/150,727 25 Aug/août 1999<br />
(25.08.1999)<br />
JP<br />
US<br />
US<br />
(30) 60/159,813 15 Oct/oct 1999<br />
(15.10.1999)<br />
(30) 60/159,838 15 Oct/oct 1999<br />
(15.10.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
US<br />
US<br />
(54) NOVEL METHOD OF TREATMENT<br />
NOUVELLE METHODE DE TRAITE-<br />
MENT<br />
(71) BEECHAM PHARMACEUTICALS<br />
(PTE) LIMITED [SG/SG]; 38 Quality<br />
Road, Jurong Industrial Estate, Jurong,<br />
Singapore 618809 (SG).<br />
(72) CONLEY, Creighton, P.; SmithKline Beecham,<br />
Bristol Industrial Park, Weaver Pike,<br />
Bristol, TN 37620 (US). ROUSH, John,<br />
A.; SmithKline Beecham, Bristol Industrial<br />
Park, Weaver Pike, Bristol, TN 37620 (US).<br />
STORM, Kevin, H.; SmithKline Beecham,<br />
Bristol Industrial Park, Weaver Pike, Bristol,<br />
TN 37620 (US).<br />
(74) GIDDINGS, Peter, John et al. / etc.;<br />
Corporate Intellectual Property, SmithKline<br />
Beecham, Two New Horizons Court,<br />
Brentford, Middlesex TW8 9EP (US).<br />
(81) AE AG AL AU BA BB BG BR CA CN CZ<br />
DZ EE GE GH GM HR HU ID IL IN IS JP<br />
KP KR LC LK LR LT LV MA MG MK MN<br />
MX NO NZ PL RO SG SI SK SL TR TT<br />
TZ UA UZ VN YU ZA; AP (GH GM KE<br />
LS MW SD SL SZ TZ UG ZW); EA (AM<br />
AZ BY KG KZ MD RU TJ TM); EP (AT<br />
BE CH CY DE DK ES FI FR GB GR IE IT<br />
LU MC NL PT SE); OA (BF BJ CF CG CI<br />
CM GA GN GW ML MR NE SN TD TG).<br />
(51) 7 A61K 9/20, A61P 31/04, A61K 31/43 //<br />
(A61K 31/43, 31:<strong>42</strong>)<br />
(11) WO 00/61116 (13) A2<br />
(21) <strong>PCT</strong>/IB00/00992<br />
(22) 11 Apr/avr <strong>2000</strong> (11.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 60/129,074 13 Apr/avr 1999<br />
(13.04.1999)<br />
(30) 60/150,727 25 Aug/août 1999<br />
(25.08.1999)<br />
(30) 60/159,813 15 Oct/oct 1999<br />
(15.10.1999)<br />
US<br />
US<br />
US<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) NOVEL METHOD OF TREATMENT<br />
NOUVEAU<br />
MENT<br />
PROCEDE DE TRAITE-<br />
(71) BEECHAM PHARMACEUTICALS<br />
(PTE) LIMITED [SG/SG]; 38, Quality<br />
Road, Jurong Industrial Estate, Jurong,<br />
Singapore 618809 (SG).<br />
(72) CONLEY, Creighton, P.; 226 Galway<br />
Road, Bristol, TN 37620 (US). ROUSH,<br />
John, A.; 2009 Buckingham Court, Kingsport,<br />
TN 37620 (US). STORM, Kevin, H.;<br />
837 Huntley Road, Bristol, TN 37620 (US).<br />
(74) GIDDINGS, Peter, John; SmithKline Beecham,<br />
Corporate Intellectual Property, Two<br />
New Horizons Court, Brentford, Middlesex<br />
TW8 9EP (GB).